Health Secretary Wes Streeting expressed gratitude for the opportunity to meet former Little Mix member Jesy Nelson and commended her for sharing her personal story. Nelson met with Streeting to advocate for newborn screening for spinal muscular atrophy (SMA), a condition that afflicts her twin babies. The heartbreaking diagnosis means that her children may never be able to walk.
The Mirror is campaigning for the inclusion of a simple £5 SMA check in the NHS newborn heel prick test, enabling early treatment and potential cure before irreparable nerve damage occurs. Streeting acknowledged Nelson’s bravery in discussing her family’s challenges and emphasized the importance of her advocacy in raising awareness among families facing similar struggles.
Streeting highlighted the progress being made in response to Nelson’s plea, mentioning the UK National Screening Committee’s recommendation for a large-scale study on newborn SMA screening. He noted that more treatment options are now available for SMA, leading to improved outcomes for affected children.
The meeting between Nelson, the charity SMA UK, and Streeting underscored the urgent need for timely diagnoses to prevent devastating consequences. ITV’s This Morning will air footage of the meeting, shedding light on the issue to a wider audience.
Novartis, a pharmaceutical company, estimated that 33 babies in the UK are left in wheelchairs annually due to late SMA diagnosis. Zolgensma, a gene therapy offered by the NHS since 2021, has proven effective in preserving motor function if administered early in a child’s life.
Novartis UK’s Chief Medical Officer, Rob Hastings, expressed sympathy towards Nelson’s family and urged the government to expand newborn SMA screening nationwide. The therapy targets the genetic root cause of SMA, offering a chance for affected infants to lead healthier lives.
Late-diagnosed SMA children often require extensive medical support, including wheelchairs and breathing assistance. Nelson’s public disclosure of her twins’ condition has sparked a necessary conversation on the importance of early screening and intervention.
Nelson’s determination to advocate for better healthcare practices for SMA highlights the pressing need for increased awareness and accessibility to life-saving treatments. Her efforts have shed light on the challenges faced by families dealing with this debilitating disease.